Mohammed A. Marei
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Blinatumomab and ponatinib with central nervous system treatment intensification for adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: April 16, 2026
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysis.
Journal: Bone marrow transplantation
Published: December 03, 2025
Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 25, 2025
Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 21, 2025
Patterns of Graft-Versus-Host Disease (GvHD) Prevention Practices in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Global Study.
Journal: Hematology/oncology and stem cell therapy
Published: February 07, 2025
Acute and chronic graft-versus-host disease treatment and management in the Eastern Mediterranean region: A Worldwide Network for Blood and Marrow Transplantation survey.
Journal: Hematology/oncology and stem cell therapy
Published: February 07, 2025
Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 06, 2024
De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion.
Journal: Hematology (Amsterdam, Netherlands)
Published: November 30, 2022
Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 11, 2021
Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?
Journal: Hematology/oncology and stem cell therapy
Published: July 26, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026